Navigation Links
Prevention of Vision Loss

AMD, which is caused by a deterioration of the retina, is the number one cause of blindness among older people. A simple vitamin supplement could significantly // reduce the number of people with vision loss from age-related macular degeneration, or AMD, finds a new study.

A couple of years ago, researchers conducted a large study to see if a combination of the antioxidant vitamins C, E, and beta carotene, along with zinc oxide or zinc alone could slow down or prevent AMD among those considered at high risk for the advanced form of the condition. Results showed a significant effect for those taking the high dose supplements.

In this study, researchers first estimated about 8 million people 55 and older have early signs of AMD and are at high risk of developing advanced disease and significant vision loss. About 1.3 million, they say, would go on to develop advanced AMD without preventative treatment.

This suggests more than 300,000 of these people could avoid advanced AMD over the next five years if they took the vitamin supplements recommended by the earlier study. Thus researchers conclude, “Avoiding the development of advanced AMD can have a major effect on the quality of life for an individual ... These data suggest that the recommendations of such a supplement for those individuals should have a major impact on them as well as on the public health.”


'"/>




Page: 1

Related medicine news :

1. Prevention is better than cure
2. Prevention of cataracts
3. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
4. Simple Stroke Prevention is Best
5. Prevention of Prostate Cancer
6. Prevention of Rickets
7. Suicide Prevention Program – Having its Intended Effec
8. The Key To Prevention Of Heart Disease In Adults
9. Stroke Prevention
10. Prevention Of Recurrent Leg Ulcers
11. Solutions Being Sought For Prevention Of Rickets
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prevention Vision Loss

(Date:12/2/2008)... UCSF Medical Center ranks No....k patients are treated using balloon angioplasty, ...stry (NCDR). , (Vocus) De...nationwide for the speed with which heart attack p...ording to the National Cardiovascular Data Registr...
(Date:12/2/2008)...antic relationships establish special bonds betwee...o permanent partnerships, and ultimately, the star... partners place too much emotional weight on their...to evaluate their self-worth solely based on the o...at psychologists term as relationship-contingent s...
(Date:12/2/2008)...GO, Dec. 2 Breast-Specific Gamma I...itive imaging technique for the diagnosis of,inva...ose breast cancer. BSGI,is a molecular breast ima...,tissue density and discover very early stage can...d magnetic resonance imaging (MRI), BSGI has the,...
(Date:12/2/2008)...NGTON, Dec. 2 In an ope... Association of Homes and Services for the Aging (...d four ways that the Obama administration can make...ions to the way America cares for its most vulnera... , Expand the Nation,s Work Force: Create Jobs ...
Breaking Medicine News(10 mins):Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
...earchers on the medical histories of patients not ...her blind or suffered weak eyesight, revealed that...eries, which could have caused Vitamin A deficienc...is report is available in the latest issue of the ...
She was abandoned by her biological parents a few hours after birth and left to drown in an irrigation canal in Punjab //. But the little infant survived that and has even undergone a critical heart s
...he immense health benefits of fish oil for pregnan...ributes, even before //they arrive into the world....lsy are significantly lowered with consumption of ...evealed. The benefit is double, because it directl...
...tial for our body functioning. According to a rece...colleagues //from the American Cancer Society, Atl... the severity of prostate cancer. It does not lowe...ults of the study were published in the American J...
Other Medicine News:
(Date:12/2/2008)...ICAGO, Dec. 3 Breast-sp...etection of cancers not found on mammograms or by,...ay at the annual meeting of,the Radiological Soci...entify the most difficult to detect breast cancer-...hel F. Brem, M.D., professor of,radiology and dir...
(Date:12/2/2008)...THESDA, Md., Dec. 2 Micr...company developing novel, proprietary antibodies f...mmune diseases, today announced that it has entere... Financing Facility (CEFF) with Kingsbridge Capita...terms of the agreement, Kingsbridge has committed ...
(Date:12/1/2008)...NGAPORE, Dec. 1 S*BIO Pte Ltd toda... trial of SB1518, a potent and orally-active JAK2 ... for patients with chronic idiopathic myelofibrosi...luate the safety and tolerability of SB1518 in pat...patients. The Phase 1 part of the study will asse...
(Date:12/1/2008)...YMOUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/...nnounced that dosing of subjects has begun in stud...g dose Phase 1b study of trodusquemine (MSI-1436) ... is a novel therapeutic for the treatment of type ...eripherally to regulate insulin and leptin pathway...
Breaking Medicine Technology:New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3North American environmental commission launches trinational vaquita conservation plan 5620 1North American environmental commission launches trinational vaquita conservation plan 5620 2Color Red Makes Men Amorous 27965 1Color Red Makes Men Amorous 27965 2Color Red Makes Men Amorous 27965 3New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD 8665 1New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD 8665 2New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD 8665 3New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD 8665 4 Capella University Launches PhD in Counselor Education and Supervision 3A The new degree program one of few available online addresses growing ne 27958 1 Capella University Launches PhD in Counselor Education and Supervision 3A The new degree program one of few available online addresses growing ne 27958 2 Capella University Launches PhD in Counselor Education and Supervision 3A The new degree program one of few available online addresses growing ne 27958 3
... ERBITUX with,chemotherapy in recurrent and/or met...t of improving overall survival --, NEW YORK, Apri...ms Incorporated and Bristol-Myers Squibb Company a...f ERBITUX(R) (Cetuximab),combined with platinum-ba...asing overall survival in patients with recurrent ...
... results compared to,sumatriptan, RESEARCH TRIANGL...wswire-FirstCall/ -- -- Findings from two pivotal ...rers demonstrated that,Trexima(TM) provided superi...pared to placebo, and two through 24-hour sustaine... monotherapy. The,results were published today in ...
Other Medicine Technology:Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 2Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 3Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 4Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 5Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 6Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 7Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 8Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 9Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 2Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 3Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 4Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 5
Used for temporary internal drainage from the ureteropelvic junction to the bladder. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; C-Flex
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: